M Stuschke, M R Nowrousian. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useCombined Modality TherapyCyclophosphamide/therapeutic useDoxorubicin/therapeutic useFollow-Up StudiesHumansLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Large B-Cell, Diffuse/mortalityLymphoma, Large B-Cell, Diffuse/radiotherapyLymphoma, Non-Hodgkin/drug therapyLymphoma, Non-Hodgkin/mortalityLymphoma, Non-Hodgkin/radiotherapyMiddle AgedPrednisone/therapeutic useRadiotherapy DosageRadiotherapy, AdjuvantTerminology as TopicTime FactorsVincristine/therapeutic use
Substances： See more » VincristineDoxorubicinCyclophosphamidePrednisone
Year: 1998 PMID： 9581184 DOI： 10.1007/BF03038531
Source DB: PubMed Journal: Strahlenther Onkol ISSN： 0179-7158 Impact factor: 3.621